CBT-005(C-Biomex)

N/A

Report date: 2025/08/08 14:36:37
NME

Base Information

Drug NameCBT-005(C-Biomex)
Drug Alias NameCBT-005(C-Biomex)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAtrial natriuretic peptide receptor type B modulators
TargetsAtrial natriuretic peptide receptor type B
Therapy Area/IndicationsAchondroplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC-Biomex Ltd
China Registration ClassN/A

Develop Information

Active CompaniesC-Biomex Ltd
Inactive CompaniesN/A
Active IndicationsAchondroplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A